Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
Status:
Withdrawn
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled study intended to examine the effects of the neutraceutical
citicholine, together with omega-3 fatty acids, on a range of measures in individuals with
concussive head injury, often referred to as traumatic brain injury, or TBI. The study will
consist of three visits, during which participants will complete brain scans, a thorough
testing battery and a clinical interview to assess mood and other diagnostic information
relevant to the study.